Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Faron Pharmaceuticals Oy | 0.00 | -27.11m | 66.07m | 25.00 | -- | -- | -- | -- | -0.2538 | -0.2538 | 0.00 | -0.136 | 0.00 | -- | -- | 0.00 | -119.80 | -227.46 | -304.25 | -1,738.54 | -- | -- | -- | -- | -- | -1.65 | 3.64 | -- | -- | -- | 16.24 | -- | 17.71 | -- |
| Hemogenyx Pharmaceuticals PLC | 0.00 | -7.81m | 71.16m | 16.00 | -- | -- | -- | -- | -2.21 | -2.21 | 0.00 | -0.1089 | 0.00 | -- | -- | 0.00 | -169.60 | -87.04 | -210.76 | -102.48 | -- | -- | -- | -- | -- | -2.14 | 1.33 | -- | -- | -- | 16.01 | -- | 2.20 | -- |
| Bioventix PLC | 13.12m | 7.58m | 80.99m | 16.00 | 10.75 | 7.01 | 10.55 | 6.17 | 1.44 | 1.44 | 2.49 | 2.21 | 0.9864 | 1.84 | 2.10 | 819,741.90 | 57.04 | 58.17 | 64.40 | 64.19 | 90.86 | 92.79 | 57.83 | 61.84 | 8.65 | -- | 0.00 | 105.34 | -3.61 | 4.92 | -6.33 | 1.04 | -43.71 | 11.26 |
| 4Basebio PLC | 1.78m | -14.41m | 85.46m | -- | -- | 4.49 | -- | 48.04 | -0.9923 | -0.9923 | 0.1226 | 1.23 | 0.0729 | 1.54 | 21.56 | -- | -59.05 | -36.81 | -64.81 | -40.98 | 61.55 | 69.88 | -809.95 | -1,160.83 | 11.15 | -95.30 | 0.4485 | -- | 84.39 | 35.80 | -60.90 | -- | 50.57 | -- |
| Scancell Holdings Plc | 4.71m | -5.51m | 139.06m | 60.00 | -- | -- | -- | 29.52 | -0.0053 | -0.0053 | 0.0047 | -0.0081 | 0.2946 | -- | 8.26 | 78,516.66 | -34.46 | -33.29 | -- | -44.23 | 94.95 | -- | -116.98 | -502.03 | -- | -- | 2.07 | -- | -- | -- | -109.46 | -- | 124.48 | -- |
| Puretech Health PLC | 4.74m | 37.58m | 296.72m | 56.00 | 7.99 | 1.06 | 11.32 | 62.60 | 0.1537 | 0.1537 | 0.0197 | 1.16 | 0.0113 | -- | 2.81 | 84,637.38 | 5.63 | -3.27 | 6.57 | -3.83 | -- | -- | 498.87 | -253.25 | -- | -- | 0.0537 | -- | 44.98 | -13.21 | 181.45 | -33.81 | -75.53 | -- |
| Avacta Group Plc | -11.09m | -33.09m | 297.28m | 151.00 | -- | 1,845.43 | -- | -- | -0.0891 | -0.1579 | -0.0298 | 0.0004 | -0.1872 | -- | -- | -73,456.95 | -55.83 | -43.48 | -129.38 | -78.27 | -- | 63.54 | -- | -781.44 | 0.7883 | -0.4837 | 0.993 | -- | -96.04 | -- | -0.9503 | -- | -- | -- |
| Oxford BioMedica plc | 151.21m | -37.07m | 801.39m | 900.00 | -- | 21.50 | -- | 5.30 | -0.3539 | -0.3539 | 1.46 | 0.3084 | 0.6556 | 5.25 | 4.25 | 175,626.00 | -16.95 | -20.23 | -23.87 | -25.48 | 44.12 | 49.36 | -25.85 | -45.03 | 1.67 | -4.81 | 0.7631 | -- | 43.84 | 14.99 | 72.58 | -- | -21.89 | -- |
Data as of Feb 27 2026. Currency figures normalised to Avacta Group PLC's reporting currency: UK Pound GBX
21.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Hargreaves Lansdown Fund Managers Ltd.as of 01 Oct 2025 | 35.35m | 8.10% |
| Conifer Management LLCas of 05 Jun 2025 | 11.66m | 2.67% |
| Lombard Odier Asset Management (Europe) Ltd.as of 05 Jun 2025 | 11.66m | 2.67% |
| IG Markets Ltd.as of 01 Oct 2025 | 11.40m | 2.61% |
| HSBC Global Asset Management (UK) Ltd.as of 01 Oct 2025 | 7.08m | 1.62% |
| Unicorn Asset Management Ltd.as of 01 Oct 2025 | 4.30m | 0.99% |
| AXA Investment Managers UK Ltd.as of 31 Dec 2025 | 3.41m | 0.78% |
| Evelyn Partners Investment Management Services Ltd.as of 01 Oct 2025 | 3.02m | 0.69% |
| HSBC Bank Plc (Market-Maker)as of 01 Oct 2025 | 2.97m | 0.68% |
| Rathbones Investment Management Ltd.as of 01 Oct 2025 | 2.06m | 0.47% |
More ▼
Data from 30 Sep 2025 - 02 Feb 2026Source: FactSet Research Systems Inc.
